Print Friendly, PDF & Email

NCT/Study#

NCT04083976 /

42756493CAN2002

A Phase 2 Study Of Erdafitinib In Subjects With Advanced Solid Tumors And Selected FGFR Gene Alterations.

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587